The EU's Antimicrobial Toolbox Needs Funding
It has been nearly a year since the Commission published its Medical Countermeasures Strategy, which laid out a toolbox approach to solving the antimicrobial innovation problem. Politicians heralded three pieces of legislation as possible vehicles for delivering the tools required to rebuild Europe's antibiotic infrastructure: the Critical Medicines Act (CMA) the Biotechnology Act and the General Pharmaceutical Legislation (GPL). Between them they were intended to incentivise novel...
.png)